BIIB

Biogen
BIIB

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$17.59B
EV
$21.93B
Shares Outstanding
146.37M
Beta
0.06

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$182.55
P/E 2025E
7.91x
P/Revenue 2025E
1.92x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Biogen Inc.

gainify
BIIB

Biogen Inc.

BIIB

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FA...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Viehbacher, Christopher

Employees

7,605

IPO Date

1991-09-17

Headquarters

225 Binney Street, Cambridge, Massachusetts, 02142, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved